We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Home » GSK Settles Avandia Heart Attack Case on Trial’s Eve
GSK Settles Avandia Heart Attack Case on Trial’s Eve
January 31, 2011
GlaxoSmithKline Plc (GSK) said it settled on the eve of trial a lawsuit alleging its Avandia diabetes drug caused a North Carolina man to die of a heart attack, avoiding a jury determination over risks associated with the medicine. San Francisco Chronicle
